Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADA-HF acetazolamide pilot study in hospitalized heart failure
ISRCTN13060336Phase 2Completed
- Sponsor
- Hull University Teaching Hospitals
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of acetazolamide in heart failure (HF) (2 arms), sponsored by Hull University Teaching Hospitals. Primary endpoints: Mean net fluid loss and Serum chloride concentration. Started Jan 2023; status: completed.
02
Drugs
acetazolamide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ISRCTN13060336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13060336.